報價延遲最少15分鐘:2025/04/12 04:14 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.9 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-2.00/-2.11
|
|
企業價值
38.35M
|
| 資產負債 |
|
每股賬面淨值
3.56
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
53.48M
|
|
每股收益
3.92
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/04/12 04:14 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. |